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Abstract 
 Hormone replacement therapy has been used for decades to treat hormonal imbalances in 
women and more recently men. The purpose of this literature review was to evaluate different 
hormones used in this common practice and evaluate them for efficacy and safety. Research was 
conducted using PubMed and other databases from the Grand Valley State University Library. 
Keywords such as “hormone replacement therapy,” “estrogen risks,” and “hypogonadism” were 
used to evaluate peer-reviewed articles from 1993-2014. There is overwhelming evidence to 
suggest that testosterone seems to be an effective treatment for hypogonadism. Estrogen may 
also be effective if risk factors for breast cancer are taken into consideration. Hormone 
replacement therapy should utilize individual dosing and not be used long term until further 
research is conducted.  
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Introduction  
Hormone replacement is a newer form of therapy that has been integrated into common 
medicinal practices today. It began to appear in the 1960s to treat menopausal symptoms, and by 
the 1970s its popularity grew to millions of women (14). HRT today is used to treat women’s 
menopausal symptoms such as hot flashes, mood swings, and vaginal dryness as well as other 
more serious ailments. Men have also joined the movement to treat low testosterone levels which 
may help prevent other diseases such as dementia (5). The reason why hormone replacement is 
growing in popularity is due to its treatment of hormone imbalance. Rather than treating the 
symptoms themselves, it treats the underlying cause. Hormone replacement therapy is a 
prescription program that consists of sex hormones such as estrogen or testosterone administered 
to various sites of the body. Testosterone is essential for the development and maintenance of 
reproductive organs such as the testis, prostate, epididymis, seminal vesicles, and penis (17). It is 
also used to develop secondary sex characteristics such as increased muscle strength, hair 
growth, and others (17). Estrogen is a substance that “maintains secondary sex characteristics 
and organs such as mammary glands, uterus, vagina, and fallopian tubes” (8). The major 
estrogenic substances are estradiol, estriol, and estrone (8). In order to receive this type of 
treatment, the physician has to be specially trained, and the medication must be compounded at a 
specialized pharmacy. HRT is said to have many benefits, but recent studies suggest that the 
costs may outweigh them. There are certain health hazards that are concerning when placed on 
hormone therapy. Is it worth it to be on hormones if other complications arise? This literature 
review will assess the benefits and risks of testosterone and estrogen specifically in hormone 
replacement therapy and determine whether or not they are viable methods of treatment.  
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Literature Review  
Supporting Evidence for Testosterone Replacement Therapy  
 A testosterone study performed by Muraleedharan et al. (16) suggests that replacement 
therapy may increase survival of type 2 diabetics. Type 2 diabetics tend to have low testosterone. 
The researchers analyzed 581 men with type 2 diabetes and had their testosterone levels 
measured. The effects of testosterone replacement therapy were assessed with the low 
testosterone group. Mortality was increased in the low testosterone group by 17.2% compared 
with the normal testosterone group (9%). The association was significant (p=0.003). 
Testosterone replacement therapy was associated with a reduced mortality of 8.4% compared 
with the untreated group’s 19.2% (p<0.002). The researchers concluded that lower testosterone 
levels predict an increase in mortality in the long term and that testosterone may improve 
survival rates for men with type 2 diabetes.  
 Testosterone replacement therapy may also be used to treat men from suffering from both 
hypogonadism and HIV/AIDS. Those suffering from HIV/AIDS tend to also have low levels of 
testosterone.  A study performed by Blick et al. (3) explored this usage of testosterone. 849 men 
participated in a cohort where they were treated for 12 months with Testim, a testosterone 
supplement. The researchers monitored total testosterone and free testosterone, symptoms of 
depression, sexual dysfunction, body composition, and prostate-specific antigen levels. Those 
suffering from HIV/AIDS and those who did not both experienced an increase in testosterone 
levels to normal ranges. Sexual function and depression scores improved and antidepressant use 
decreased in both sides. However, body composition only improved significantly in those 
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without HIV/AIDS (p<0.05). The researchers determined that testosterone replacement may 
provide some clinical benefits regardless of whether or not a patient has HIV/AIDS.  
Testosterone replacement therapy can possibly be used to help treat inflammation as well. 
A study by Tsilidis et al. (23) examined the association of sex hormone-binding globulin with C-
reactive protein and white blood cell count. Data from 809 adult males in the National Health 
and Nutrition Examination Survey from 1999-2004 was used in the study. Upon analyzing the 
data, they concluded that high concentrations of testosterone were associated with significantly 
lower concentrations of C-reactive protein, a protein commonly seen in inflammation. However, 
no significance was seen with a lower count of white blood cells. There is evidence in this 
finding to suggest that testosterone replacement therapy may have some anti-inflammatory 
benefits. 
 Testosterone has been seen to improve psychological distress and quality of life 
according to a study done in China by Zhang et al. (26). They wanted to analyze the relationship 
between testosterone deficiency and psychological well-being as well as quality of life. 160 
participants were randomized into an experimental or placebo group and asked to complete 
questionnaires about aging male symptoms, anxiety, depression, stress, and overall health. Men 
received treatment for six months. Anxiety improved significantly in the experimental group 
after six months (p<0.05) as well as depression scores (p<0.05). The scores regarding stress also 
decreased significantly (p<0.05) as well as scores for overall health (p<0.05). There was no 
measureable change in the control group after six months. Researchers concluded that 
testosterone replacement not only improves deficiency symptoms but may also improve 
psychological issues.  
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 Testosterone replacement for hypogonadism alone was observed by Miner et al. (15) for 
twelve months. They used the Testim Registry in the United States to conduct their research. The 
Testim Registry is a prospective, observational cohort of men who were prescribed Testim. This 
registry has measurements of total testosterone and free testosterone, prostate-specific antigen, 
sexual function, mood/depression, and cardiometabolic criteria before and after testosterone 
replacement. 849 participants were used, and 743 of them were given the drug. Mean total and 
free testosterone increased significantly after the use of TRT (p<0.001 and p<0.001 
respectively). Mean PSA levels also increased significantly (p<0.004). There were significant 
improvements in sexual function, mood, depression, and cardiometabolic measurements as well. 
As a result, the researchers established that testosterone deficiency symptoms improved with 
TRT in men. 
 Another trial with testosterone that yielded positive results for men with hypogonadism 
was performed by Dobs et al. (7). This was an open label, noncomparative trial of men with low 
testosterone. The goal of the study was to determine the pharmacokinetics and safety of a 
testosterone 2% gel. 129 patients were included in the results. After three months, 100 patients 
had total testosterone concentrations within the normal physiological range. The gel was well-
tolerated with only mild to moderate skin reactions. 2% testosterone restored testosterone levels 
in 75% of patients with only a low risk of high levels. The researchers determined testosterone 
replacement therapy of this sort to be safe and effective with minimal adverse effects. 
Opposing Evidence for Testosterone Replacement Therapy  
Despite all the positive factions associated with testosterone therapy, He et al. (11) 
studied the cardiometabolic risks that may be associated with it. They recruited 112 men ages 65-
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90 to participate. The research was double blind and used a placebo to ensure quality. 
Transdermal testosterone was administered for 16 weeks. Testosterone levels, body composition, 
and cardiometabolic risk factors such as upper body fat, blood pressure, insulin sensitivity, 
fasting triglycerides, and HDL-cholesterol were measured. The researchers found that some of 
the cardiometabolic factors such as total fat, triglycerides, and HDL-cholesterol improved. Other 
risk factors such as systolic blood pressure and insulin sensitivity worsened. Overall, 
cardiometabolic risk scores improved significantly (p<0.001). The study concluded that there are 
diverse changes in cardiometabolic risks, but overall testosterone therapy did not appear to 
worsen the risk in healthy older men.  
Supporting Evidence for Estrogen Replacement Therapy  
 Estrogen is another popular hormone used in replacement therapy for women. One of the 
ways that it may be beneficial for people is to treat hormone imbalances and resulting 
menopausal symptoms. Therefore, many clinical trials have been studied for this purpose. One 
such study was done by Botelho et al. (4). They analyzed the effects of a hormone supplement 
and its use to treat menopausal symptoms. The supplement consisted of estradiol, estriol and 
progesterone. 66 women with symptoms received transdermal hormones in the forearm for 60 
months. An improvement was made in symptoms for 92.5% of women. Researchers also found 
no adverse effects. A mammography was performed to check for breast cancer or abnormalities. 
As a result of this study, researchers concluded that hormone replacement with this design was 
safe and effective in treating menopausal symptoms.   
Another study by Chittacharoen et al. (6) corroborates these results. An open, 
uncontrolled phase IV clinical trial was performed on 39 perimenopausal or postmenopausal 
HORMONE REPLACEMENT THERAPY  8 
 
women. They received an oral supplement of estradiol and levonorgestrel for six cycles. A 
menopause rating scale was used to measure severity of symptoms. During the first treatment, 
the general score decreased by 34.9% after 3 months. Psychological complaints decreased by 
34.1% and urogenital complaints decreased by 29.3% after three months. It appears as though at 
least three months of administration of this supplement caused alleviation of menopausal 
symptoms by a considerable amount.  
Saure, Planellas, Poulsen, and Jaszczak (19) studied a newer combination of hormones 
and its alleviation of menopausal symptoms. This new formulation, an estradiol combination 
supplement called Liesta, was compared to another common hormone replacement treatment. 
376 perimenopausal women were randomly selected to receive Liesta or the other treatment for 
six cycles. All the treatments resulted in reduced menopausal symptoms. Hot flashes were no 
longer present in 71% of the women in the Liesta group and 62% of the other women. 
Perspiration decreased from 80 to 65% of women in the Liesta group and from 82 to 63% in the 
other group. Mood swings also decreased from 82 to 52% in the Liesta group. There is evidence 
to support that both regimens alleviated menopausal symptoms. 
A study performed by Ushiroyama, Atsushi, Sakuma, KouUeki, and Minoru (24) 
examined estrogen’s specific effect on a common complaint of menopausal women. They looked 
at the association between blood flow in the extremities and hot flashes compared to changes in 
blood flow after estrogen replacement therapy. The study utilized 131 post-menopausal women 
and treated them with HRT. Before treatment, those who experienced hot flashes had higher 
blood flow under the jaw than those who did not. Once the estrogen treatment was administered, 
blood flow at the site decreased significantly (p<0.0001). HRT may have therapeutic effects for 
post-menopausal women suffering from hot flashes. 
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Besides menopausal symptoms, estrogen replacement may also have other benefits. 
Estrogen may promote skeletal muscles regeneration. A study by Velders and Diel (25) suggests 
this notion based on several animal and controlled human studies that they analyzed. Skeletal 
muscle normally declines with age, but sex hormones may be able to slow the process. The 
animal studies they studied used estrogen receptor antagonists and receptor selective agonists as 
their method of measurement. The studies determined that estrogen reduces leukocyte invasion 
and increases satellite cell numbers during the regeneration of skeletal muscle. Human studies 
have not been as clear, but they do support this concept. It appears as though hormonal therapies 
plus exercise help increase tissue mass.  
Estrogen may also be able to help manage oxidative stress and improve quality of life 
according to Sanchez et al. (21). They executed a clinical trial that was controlled and had 111 
perimenopausal participants. The women were divided into three groups: premenopausal women 
in a control group, postmenopausal women receiving HRT, and postmenopausal women 
receiving a placebo. Lipoperoxides were used as the biochemical marker to measure oxidative 
stress levels. The results were that levels of lipoperoxides were higher in postmenopausal women 
with low quality of life (p<0.05). Those who received the estrogen supplement with a lower 
quality of life saw diminished plasma lipoperoxides in six months (p<0.01). Therefore, the 
researchers decided that estrogen therapy improves quality of life and reduces lipoperoxides in 
postmenopausal women.  
Estrogen therapy may also be possibly used to treat asthma according to Ticconi, 
Pietropolli, and Piccione (22). Their review analyzed many studies performed to determine 
whether estrogen replacement therapy is a viable treatment for asthmatic symptoms. Their reason 
for doing this is that estrogen has significant effects on normal airway function. It can work 
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directly on airway reactivity or indirectly through regulation of inflammation and immune 
response in the lungs. Naturally it would seem that replacing estrogen would improve asthma 
symptoms. Unfortunately, the impact of ERT on asthma was not determined at the end of this 
review. The extensive available data shows that estrogen has a large impact on airway function, 
but it is inconsistent and unclear.  
Recently it has been thought that estrogen may be used to improved cognitive function as 
well. However another study by Espeland et al. (9) suggests otherwise. Cognitive testing on 
postmenopausal women was performed 7.2 years after the hormone therapy was administered to 
them. 1326 women with a mean age of 67.2 years participated in the study. Global cognitive 
function scores were similar for those who received treatment and those who were given a 
placebo (p=0.66). There was also not a difference in any other areas of cognition that were 
measured (p=0.15). The researchers determined that there was neither benefit nor risk to taking 
hormone replacement therapy with cognition. 
Opposing Evidence for Estrogen Replacement Therapy  
As effective as estrogen therapy may seem to appear, it has also been the subject of 
recent debate. Several publications have come out that indicate serious adverse effects that may 
be associated with HRT. Amadou et al. (1) demonstrate this in their research of cancer. Data 
from a Mexican multi-center population-based case-control study of women was analyzed. Over 
2000 participants were analyzed from 2004-2007 using a questionnaire. The result of this study 
was that there was a significant increase in the odds ratio risk of breast cancer in individuals 
using hormone replacement therapy (OR: 1.45). Therefore, the researchers concluded that HRT 
had a significant effect on post-menopausal breast cancer in this population of Mexican women.  
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Another study of hormone replacement therapy’s association with cancer was published 
by the Journal of the Gynecological Endocrinology (12). This article offers a mechanism behind 
sex therapy’s cancer-causing ability as well as the risk of long-term usage. Sex hormones are not 
known to damage DNA directly, but they can stimulate or inhibit cell proliferation. Since tumors 
are the result of uncontrolled cell proliferation, hormones can manipulate tumor progression. 
According to their study of long term usage, the risk of having breast cancer diagnosed increases 
by 1.023 each year. As a result, this study suggests that HRT should only be used as treatment if 
patients suffering from menopausal symptoms have not experienced relief from alternative 
methods. It is also suggested that patients give informed consent before making the decision to 
proceed with therapy. 
Breast cancer risk has been noticed in other studies of ERT as well. A study by Farhat et 
al. (10) suggests that estradiol and estrone replacement may increase the risk. A nested case-
control study within the clinical trial performed by the Women’s Health Initiative was done 
using 16608 postmenopausal women. Women were 50 to 79 years of age and had no history of 
breast cancer. 348 breast cancer subjects and 348 controls were selected and matched. Sex 
hormone levels were measured at baseline and then again one year later. Statistically significant 
elevations in the risk for breast cancer were seen in those treated with estradiol (p<0.04) and 
estrone (p<0.007). Therefore, this is more evidence supporting the idea that ERT may cause 
cancer.  
Despite this evidence for breast cancer, other studies suggest that perhaps estrogen 
replacement therapy does not cause other types of cancer such as brain tumors. Andersen, Friis, 
Hallas, Ravn, and Gaist (2) decided to analyze the risk of gliomas in a case-control study. 
Women from 55-84 years of age with a diagnosed brain glioma were chosen for the study. 658 
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cases and 4350 controls were used. The odds ratio of hormone replacement therapy and gliomas 
is 0.9. The researchers concluded that HRT does not increase the risk for glioma in the short 
term.  
A meta-analysis was performed by Qi et al. (18) to determine whether or not HRT 
increased the risk for other types of cancer. A literature search was done using databases such as 
PubMed and EMBASE until July of 2013 without any limitations. Twelve case-control and six 
cohorts were used. The results of this study were that there is an increased risk of a meningioma 
with hormone replacement therapy (RR=1.19). The researchers concluded that long term use of 
hormones may increase the risk of meningioma in women, although the mechanism behind it is 
unknown.  
After reviewing the literature, other researchers have formed their own opinions on the 
topic of risks associated with HRT. For example, Khalil (13) came up with his own solution to 
hormone replacement therapy. His article suggests that estrogen dosage should be done 
individually. His research concerned the vascular benefits of estrogen. Cardiovascular disease is 
less common is premenopausal women than men or postmenopausal women, suggesting that 
estrogen may provide some vascular benefits. Estrogen receptors in endothelium and smooth 
muscle can signal pathways that lead to vasodilation and decreased smooth muscle contraction. 
Khalil reviewed clinical trials performed by the Women’s Health Initiative and Heart and 
Estrogen/progestin Replacement Study (HERS). These studies did not demonstrate vascular 
benefits and even showed adverse effects. Several variables had an impact on the hormonal 
effects such as age-related changes, distribution, and post-estrogen receptor signaling. Due to 
such individual factors determining the effects of HRT, Khalil concluded that hormone therapy 
should be designed appropriately for each patient.  
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Estrogen is not the only hormone that people think should be dosed individually. 
Researchers like Shoupe (20) believe that before hormone replacement therapy is administered, a 
doctor should review cardiovascular risk in each patient. He thinks that it is important to take 
into consideration a woman's age, number of years since her menopause, and a number of 
cardiovascular risk factors. Based on other studies, Shoupe believes that those who have had a 
recent cardiovascular event, current thromboembolic disease, long-standing immobilization, or 
severe peripheral arterial disease should not use hormone replacements. Otherwise, they have an 
increased risk when taking hormone supplements. 
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Discussion 
 Hormone replacement therapy can be used to treat many different ailments of the body. 
Overall, different supplements can be beneficial and restore hormone imbalances when dosed 
individually. However, long term use is questionable.  
 There is overwhelming evidence to suggest that testosterone replacement therapy may be 
used to treat hypogonadism. Treating hypogonadism may indirectly treat other ailments such as 
type 2 diabetes, HIV/AIDS, inflammation, and psychological distress. Testosterone levels 
seemed to improve in all the studies. However, to improve research quality more double blind 
and placebo-controlled studies should be performed. Open label, uncontrolled studies seemed to 
be common amongst the literature. Testosterone replacement does not appear to have any 
adverse effects, which is great for individuals at a higher risk. More long-term studies should be 
conducted to reaffirm this though. Testosterone replacement therapy seems to be safe and 
effective for healthy individuals without major heart problems.  
 Estrogen appears to also be beneficial but has more risks associated with it. Estrogen 
supplementation appears to significantly relieve symptoms of menopause. More double-blind, 
controlled studies should be performed however to ensure quality of research. Many of the 
studies that yielded significant results were open label. Also, long-term use of estrogen may 
increase the risk for breast cancer as well as meningiomas. Therefore, it is not recommended for 
long term usage. Dosing should be done individually as well. If a patient is to use estrogen 
replacement, they should be informed of the risk. Evaluating a patient’s overall risk factors such 
as age and cardiovascular trouble should prevent any other complications. Estrogen, although 
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seemingly beneficial, should be recommended only after other treatments have failed to yield 
results. 
 All patients taking hormone replacement therapy, especially women, should talk with 
their doctor to ensure it is the best method of treatment. 
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Conclusion 
 Hormone replacement therapy is a viable method of treatment. Out of the two types of 
hormones discussed in this literature review, testosterone seems to be the safest due to its lack of 
adverse effects. Both are effective in relieving hormonal imbalance and seem to be suitable 
methods of treatment. Estrogen carries with it serious possible side effects that can be deadly in 
patients with high risk. Long term usage is not recommended for either treatment until higher 
quality research is performed. Dosing should be individual and take into consideration 
cardiovascular risks as well as history of breast cancer. This will help determine predisposition to 
complications. Healthy individuals should consider usage if they are experiencing hormonal 
imbalance and have not received relief from other treatments.  
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